Question-and-Answer Session
Operator
(Operator Instructions) Your first question comes from Michael Rehaut. Your line is open.
Michael Rehaut - JPMorgan
First question just on the comments earlier on about still being restraining yourselves in terms of investments in land, and in any types of opportunities. I remember last quarter I think you did one or two very kind of small one-off deals if I remember right.
Was there any sort of similar kind of smaller one-offs this quarter? More broadly speaking, perhaps you can talk about market-by-market, where you might see perhaps more potential for return of some level of investment, which markets maybe closer to what you would require in terms of price or other factors?
Larry Mizel
Michael, you should be aware that I think in virtually every market we are in, we are very active with our land group I think probably in every market, continuing the process of evaluation of perspective transactions. The deal flow is increasing. I think that government finally getting the rules out at least for capital, and the PPIP program started.
We expect that there will be a multitude of opportunities, hopefully at the right levels that are appropriately profitable. I think in most of the markets there is probably no place that we are active in that we don't have exposure to opportunities, and we will work those really hard. As the spread comes together, we are going to be in business, and we are really very excited about it.
Michael Rehaut - JPMorgan
Just a separate question on gross margins. If I missed this I apologize. If you could break out the benefit to the gross margin, the actual dollar amount from prior impairments, I believe as you have done in the past and you also mentioned a particularly high portion of specs in the closings this quarter as a percentage of 75% I believe. If you could kind of give us what that was, perhaps last quarter and a year ago, if that is on hand?
Larry Mizel
The impairment number is in your earnings release as well, on Page 9, just a reference to everybody else. But $43 million went through our P&L and impairment and cost of goods sold for this particular quarter, $49.9 million in the prior year. And roughly the spec count was about two-thirds prior quarter and prior year.
Operator
Your next question comes from Dan Oppenheim.
- To read the full transcript on Seeking Alpha, click here »
